AIDS: responding to the crisis. A public policy agenda. NLM AIDSLINE Important note: Information in this article was accurate in 1986. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


AIDS: responding to the crisis. A public policy agenda.

Health Prog. 1986 May;67(4):30-3. Unique Identifier : AIDSLINE AHA/86224255
Gamble SW


Abstract: Health care organizations must work toward public policy that addresses the cost of treating AIDS patients. One approach to the funding of AIDS medical care--although the evolving nature of the disease's treatment may make it difficult--would be to assign a diagnosis-related group weight to AIDS. Other possible mechanisms would be to establish AIDS as a covered medical benefit under Medicare or Medicaid. The agenda for public policy should include support of vaccine liability immunity for manufacturers of a potential AIDS vaccine and the allocation of funds for health worker education. It should oppose private insurance screening for the purpose of excluding from coverage individuals with AIDS or those who test positive to the AIDS virus. Health care organizations' efforts must include more than just lobbying in Washington, DC, however. Local business leaders and business coalitions also should be involved in the dialogue and in taking the first steps toward addressing the cost of care for AIDS patients.
Keywords: Acquired Immunodeficiency Syndrome/*ECONOMICS Diagnosis-Related Groups *Health Policy Human Insurance, Health Medical Assistance *Public Health United States JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/KWDeconomicsdiagnosis-relatedgroupsKWDhealthpolicyhumaninsurance,healthmedicalassistanceKWDpublichealthunitedstatesjournalarticle
860930
M8690230


Copyright © 1986 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1986. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1986. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .